NIH-funded research R21 grant

Increasing uptake of long-acting HIV prevention and treatment among Black and Latinx men with suboptimal adherence in Southern California

Official title: Developing Status-Neutral Approaches to Increase Uptake of Long Acting Injectable PrEP and ART Among Black and Latinx Men with Less Than Optimal Adherence in Southern California

Funded at University of California, San Diego · NIH-11257130 · Data updated 2026-11-12

A study to understand barriers and create new ways to help Black and Latinx men ages 18-45 use long-acting HIV prevention and treatment options in Southern California.

More PrEP research and trials

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionUniversity of California, San Diego
NIH-funded
Lab location1 site (La Jolla, United States)
Project startJuly 15, 2026
Project endJuly 14, 2028
Funding year2026
Award (this year)$441,215
NIH project number1R21MH139447-01A1
Project IDNIH-11257130 on NIH RePORTER

Who could benefit from this research

Could help

Ideal participants are Black and Latinx men who have sex with men, aged 18-45, with suboptimal engagement in HIV care or prevention in the specified Southern California counties.

Less likely to help

Individuals who are not in the target demographic or who are already fully adherent to all HIV prevention and treatment regimens may see limited direct benefit.

What this research studies

This project focuses on Black and Latinx sexual minority men in three Southern California counties who struggle with engagement in HIV care or prevention. It will identify what makes it hard or easy to start and stick with long-acting PrEP and ART, and test new approaches to increase use and persistence. The work combines community input, targeted outreach, and pilot strategies to improve adherence and viral suppression with long-acting options. The study is led by UC San Diego and aims to generate practical steps that clinics and communities can adopt. Results could inform broader efforts to reduce HIV disparities and improve health outcomes in this population.

Why it matters

Potential benefit: If successful, the project could help more Black and Latinx men maintain long-acting HIV prevention and treatment, leading to better health and fewer new infections.

How similar studies have gone: Prior work has shown that long-acting HIV prevention and treatment can improve adherence, but barriers among Black and Latinx men in this region require targeted, community-informed approaches.

Where this research is happening

  • University of California, San Diego
    La Jolla, United States
    Active

Researchers

  • Principal investigator: Campbell, Chadwick Karl — University of California, San Diego
  • Study coordinator: Campbell, Chadwick Karl

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.